ABBV vs SAM · P/E 81, rev $61.16B vs rev $2.01B
AbbVie Inc (ABBV) versus Boston Beer Company Inc (SAM) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Boston Beer Company Inc (SAM) is a beverages - brewers company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported SAM revenue for 2024-12-28 was $2.01B. Net income was $59.7M. Revenue was up 0.2% from 2023-12-30 to 2024-12-28. SAM currently screens at market cap $1.79B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. SAM currently screens at market cap $1.79B.
Not investment advice. Open the ABBV and SAM stock pages for the full models.
Not investment advice.